These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12084454)

  • 21. More than a messenger: Alternative splicing as a therapeutic target.
    Black AJ; Gamarra JR; Giudice J
    Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
    El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
    J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of splice sites to antisense oligonucleotides in vivo.
    Sierakowska H; Sambade MJ; Schümperli D; Kole R
    RNA; 1999 Mar; 5(3):369-77. PubMed ID: 10094306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative Splicing as a Target for Cancer Treatment.
    Martinez-Montiel N; Rosas-Murrieta NH; Anaya Ruiz M; Monjaraz-Guzman E; Martinez-Contreras R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
    Flanagan WM; Su LL; Wagner RW
    Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of alternative splicing by antisense therapeutics.
    Kole R; Vacek M; Williams T
    Oligonucleotides; 2004; 14(1):65-74. PubMed ID: 15104897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond.
    Coppelli FM; Grandis JR
    Curr Pharm Des; 2005; 11(22):2825-40. PubMed ID: 16101440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense oligonucleotide-mediated inhibition of mutant p53 expression.
    Ruddell CJ; Green JA; Tidd DM
    Biochem Soc Trans; 1996 Aug; 24(3):410S. PubMed ID: 8878954
    [No Abstract]   [Full Text] [Related]  

  • 32. Making antisense of splicing.
    Garcia-Blanco MA
    Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids.
    Wan L; Kral AJ; Voss D; Schäfer B; Sudheendran K; Danielsen M; Caruthers MH; Krainer AR
    Nucleic Acid Ther; 2024 Aug; 34(4):188-198. PubMed ID: 38716830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
    Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
    Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
    Hodges D; Crooke ST
    Mol Pharmacol; 1995 Nov; 48(5):905-18. PubMed ID: 7476922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
    Dominski Z; Kole R
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8673-7. PubMed ID: 8378346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.
    Suwanmanee T; Sierakowska H; Lacerra G; Svasti S; Kirby S; Walsh CE; Fucharoen S; Kole R
    Mol Pharmacol; 2002 Sep; 62(3):545-53. PubMed ID: 12181431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.
    Wojtuszkiewicz A; Assaraf YG; Maas MJ; Kaspers GJ; Jansen G; Cloos J
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):673-89. PubMed ID: 25495223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.
    Garanto A; Collin RWJ
    Methods Mol Biol; 2018; 1715():61-78. PubMed ID: 29188506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.
    Kang SH; Cho MJ; Kole R
    Biochemistry; 1998 May; 37(18):6235-9. PubMed ID: 9572837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.